A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B
2017 ◽
Vol 23
(4)
◽
pp. 331-339
◽
1998 ◽
Vol 114
(5)
◽
pp. 988-995
◽
2008 ◽
Vol 23
(9)
◽
pp. 1320-1326
◽